Figure 1.

A large erythematous plaque on the site of the injection of the second dose of BNT162b2 COVID‐19 vaccine (left deltoid). The main plaque displays peripheral scale, representing an early stage of the resolution process of initial lesions. Peripheral erythematous papules, many of them surrounded by a discreet paler halo, can be seen. Sutures over both biopsy wounds can be noted (a). After the progression of the initial plaque on the left deltoid, similar lesions can be seen profusely involving the back and upper extremities of the patient (b)